Reuters logo
3 years ago
BRIEF-Epigenomics shares drop 47.1 pct after says FDA needs additional data on Epi proColon test
June 3, 2014 / 7:13 AM / 3 years ago

BRIEF-Epigenomics shares drop 47.1 pct after says FDA needs additional data on Epi proColon test

FRANKFURT, June 3 (Reuters) - Epigenomics AG : * Shares drop 47.1 percent after says FDA needs additional data on epi procolon

test

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below